The CliniMACS® Plus Instrument
provides a flexible, open platform technology for the isolation of many cell types, such as monocytes, dendritic cells, NK cells, T cells, and B cells. The CliniMACS Plus Instrument is CE-marked for clinical use in Europe. In the US, the CliniMACS System components, including CliniMACS Reagents, are available for use only under an approved Investigational New Drug (IND) application or Investigational Device Exemption (IDE).
Regular service of the CliniMACS Plus Instrument is essential to ensure that this medical device meets stringent quality control and regulatory requirements. Three scheduled service contracts are currently available for the CliniMACS Plus Instrument: Planned Maintenance, Full Service, and Full Service Premium.
Here you can download detailed information on CliniMACS Instrument Service Contracts